• Home   ›
  •   Global Tenders   › Tender Reference No: 100921179

    • Tenders Are Invited For Antivirals For Systemic Use - Delivery Of Medicinal Products For 2025, Granted In Accordance With Ordinance No. 34 Of 25.11.2005 For The Order For Payment From The Hold. Budget For The Treatment Of Bulgarian. Call. For Diseases, Outside The Scope Of Obligation, For The Treatment Of Patients With Hiv/Aids, Tuberculosis, Psycho. And Behavioral Disorders Due To The Use Of Opioids, Addiction Syndrome - Emtricitabine/Tenofovir Disorroxil

    Tender Detail

    100921179
    You can view only after subscription.
    545665-2025
    Self-Funded
    Tenders Are Invited For Antivirals For Systemic Use - Delivery Of Medicinal Products For 2025, Granted In Accordance With Ordinance No. 34 Of 25.11.2005 For The Order For Payment From The Hold. Budget For The Treatment Of Bulgarian. Call. For Diseases, Outside The Scope Of Obligation, For The Treatment Of Patients With Hiv/Aids, Tuberculosis, Psycho. And Behavioral Disorders Due To The Use Of Opioids, Addiction Syndrome - Emtricitabine/Tenofovir Disorroxil
    NCB
    You can view only after subscription.
    Eastern Europe
    Balkans,European Union,G20
    03-09-2025

    Work Detail

    Antivirals For Systemic Use - Delivery Of Medicinal Products For 2025, Granted In Accordance With Ordinance No. 34 Of 25.11.2005 For The Order For Payment From The Hold. Budget For The Treatment Of Bulgarian. Call. For Diseases, Outside The Scope Of Obligation, For The Treatment Of Patients With Hiv/Aids, Tuberculosis, Psycho. And Behavioral Disorders Due To The Use Of Opioids, Addiction Syndrome - Emtricitabine/Tenofovir Disorroxil. “Delivery Of Medicinal Products For 2025, Granted Pursuant To Ordinance No. 34 Of 25.11.2005 On The Order For Payment By The State Budget Of Treatment Of Bulgarian Citizens For Diseases, Outside The Scope Of Compulsory Health Insurance, For The Treatment Of Patients With Hiv/Aids, Emtricitabine/ Tenofovir Disoproxil With Decision No. F631841/ 31.03.2025. The Ministry Of Health Has Opened A Procedure With The Subject:“ Delivery Of Medicinal Products For 2025, Granted In Accordance With Ordinance No. 34 Of 25.11.2005 For The Payment Order From The State Budget Provision, For The Treatment Of Patients With Hiv/Aids, Tuberculosis, Mental And Behavioral Disorders Due To The Use Of Opioids, Dependence Syndrome, Including 23 (Twenty-Three) Self-Separate Positions (00080-2025-0006). On The Grounds Of Art. 110, Para. 1, Item 1 Of The Public Procurement Act, Due To The Lack Of Tenders Submitted, The Procedure Was Terminated In Lot No 8 Emtricitabine/Tenofovir Disoproxil. The Antiretroviral Medicinal Product Emtricitabine/Tenofovir Disoproxil In The Termination Position Is Required For The Therapeutic Regimens Of The Patients Prescribed Because Of Its Specific Therapeutic Indications And Pharmacological Characteristics. In 2025, For The Treatment Of Emtricitabine/Tenofovir Disoproxil, 603 Patients Were Provided, Respectively 7 236 Packs (217 080 Tablets).

    Key Value

    Tender Value
    4,12,090 - BGN

    Attachment

    FileName File Description
    Global Tender Document Tender Notice
    Attachments
    Click Here To Download
    Tender Documents

    Additional Details Available on Click
    ✓ Tendering Authority
    ✓ Publication Document
    (Tender Document / Tender Notice )
    RBbranding
    Disclaimer :
    We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
    RBTendersdetails2
    Tell us about your Product / Services,
    We will Find Tenders for you
    Cnet Technologies

    We are a group of professionals specializing in custom software development, web development, mobile app development, IOT base solutions, web design, graphics & Enterprise solutions provid.

    About Us

    Services

    Browse Tenders

    For Sales Inquiry

    Connect With Us

    Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

    For Tender Information Services Visit : TenderDetail